Delivery Order SPE2DB22D9239-SPE2DB24FDK41

Award Date 6/20/24
Potential Completion Date 7/12/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,435.20, is for the delivery of the pharmaceutical product STELARA 130 MG/26 ML VIAL 26ML. This order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the DLA to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $3,730.56 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Stelara 130 mg/26 ml vial. This delivery order is part of a larger indefinite delivery contract worth up to $4,999,999 that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical items to support military...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $4,974.08, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Stelara (130 mg/26 ml vial) to support the recurring medical supply needs of military health facilities. This delivery order was issued under a larger indefinite delivery contract (IDC) valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,212.00, is for the delivery of STELARA (ustekinumab) 130 mg/26 ml vials to support the recurring pharmaceutical needs of military health facilities. This delivery order is placed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
The Defense Logistics Agency (DLA) awarded a $4,974.08 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Stelara 130 mg/26 ml vials and has an ultimate completion date of June 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $7,461.12 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,566,373,759 units of the pharmaceutical drug STELARA 130 MG/26 ML VIAL 26ML, with a completion date of November 20, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,730.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of 4566523970 - STELARA 130 MG/26 ML VIAL 26ML, a specialized pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, valued at...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,730.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of 130 mg/26 ml vials of Stelara, a biologic medication, with a period of performance through September 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,730.56 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Stelara 130mg/26ml pharmaceutical product, with a performance period through December 13, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,992.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract is for the supply of STELARA 90 MG/ML SYRINGE, a biologic medication, with an ultimate completion date of March 28, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA, valued up to $4,999,999, that enables the...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDK41
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $7,461.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4564977234 - STELARA 130 MG/26 ML VIAL 26ML, and has a completion date of July 12, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military healthcare facilities worldwide. The contract has no set-aside designation.

Generated 9/19/24, 9:42 AM